文献速递临床试验与 GCP医学教育与科研方法

结构化团体教育项目(MEDIHEALTH)改善马来西亚砂拉越州马来裔2型糖尿病患者用药依从性的有效性与可持续性:随机对照试验研究方案

Effectiveness and sustainability of a structured group-based educational program (MEDIHEALTH) in improving medication adherence among Malay patients with underlying type 2 diabetes mellitus in Sarawak State of Malaysia: study protocol of a randomized controlled trial.
PubMed 文献 · Trials · 2018-06-05

本研究为前瞻性平行设计随机对照试验,评估药师主导、多理论 grounding、文化敏感的结构化团体教育项目 MEDIHEALTH 对用药依从性中低水平(MMAS-8 马来版评分<6)的马来裔 T2DM 患者的有效性与可持续性,主要结局为基线及干预后1、3、6、12个月依从性,并辅以定性访谈三角验证。

要点

  • MEDIHEALTH 为药师主导、多理论支撑、文化敏感的结构化团体教育项目。
  • 纳入标准为马来裔 T2DM 且 MMAS-8 评分<6 的中低依从患者。
  • 主要结局为基线及干预后1、3、6、12个月用药依从性。

核心结论

  • 研究旨在评估 MEDIHEALTH 项目改善马来裔 T2DM 患者用药依从性的有效性与可持续性。

研究设计与样本

  • 前瞻性、平行设计、两组随机对照试验。
  • 研究对象为在 Petra Jaya 健康诊所和 Kota Samarahan 健康诊所接受药物治疗、MMAS-8 马来版评分<6 的马来裔 T2DM 患者。
  • 随机分为 MEDIHEALTH 干预组和对照组。

关键数值与推荐

  • 主要结局为基线及干预后1、3、6、12个月的用药依从性水平。
  • 次要结局为基线及干预后1、6、12个月与用药依从性相关的态度、主观规范、感知行为控制、意向和知识。
  • 干预后1个月对5名参与者进行半结构化访谈,干预后12个月对2名主要促进者和2名项目管理官员进行深度访谈。
  • 定量数据使用 SPSS 22 版和 Stata 14 版分析,定性数据使用 ATLAS.ti 8 辅助主题分析。

临床怎么用

  • 为结构化团体教育项目在马来裔 T2DM 患者中推广用药依从性提供有效性和可持续性证据。
  • 定量与定性结果可协助该项目的未来开发。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Amidst the high disease burden, non-adherence to medications among patients with type 2 diabetes mellitus (T2DM) has been reported to be common and devastating. Sarawak Pharmaceutical Services Division has formulated a pharmacist-led, multiple-theoretical-grounding, culturally sensitive and structured group-based program, namely "Know Your Medicine - Take if for Health" (MEDIHEALTH), to improve medication adherence among Malay patients with T2DM. However, to date, little is known about the effectiveness and sustainability of the Program. METHODS/DESIGN: This is a prospective, parallel-design, two-treatment-group randomized controlled trial to evaluate the effectiveness and sustainability of MEDIHEALTH in improving medication adherence. Malay patients who have underlying T2DM, who obtain medication therapy at Petra Jaya Health Clinic and Kota Samarahan Health Clinic, and who have a moderate to low adherence level (8-item Morisky Medication Adherence Scale, Malaysian specific, score <6) were randomly assigned to the treatment group (MEDIHEALTH) or the control group. The primary outcome of this study is medication adherence level at baseline and 1, 3, 6 and 12 months post-intervention. The secondary outcomes are attitude, subjective norms, perceived behavioural control, intention and knowledge related to medication adherence measured at baseline and 1, 6 and 12 months post-intervention. The effectiveness and sustainability of the Program will be triangulated by findings from semi-structured interviews with five selected participants conducted 1 month after the intervention and in-depth interviews with two main facilitators and two managerial officers in charge of the Program 12 months after the intervention. Statistical analyses of quantitative data were conducted using SPSS version 22 and Stata version 14. Thematic analysis for qualitative data were conducted with the assistance of ATLAS.ti 8. DISCUSSION: This study provides evidence on the effectiveness and sustainability of a structured group-based educational program that employs multiple theoretical grounding and a culturally sensitive approach in promoting medication adherence among Malays with underlying T2DM. Both the quantitative and qualitative findings of this study could assist in the future development of the Program. TRIAL REGISTRATION: National Medical Research Register, NMRR-17-925-35875 (IIR). Registered on 19 May 2017. ClinicalTrials.gov, NCT03228706 . Registered on 25 July 2017.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Ting CY, Ahmad Zaidi Adruce S, Hassali MA, et al. Effectiveness and sustainability of a structured group-based educational program (MEDIHEALTH) in improving medication adherence among Malay patients with underlying type 2 diabetes mellitus in Sarawak State of Malaysia: study protocol of a randomized controlled trial. Trials. 2018. PMID: 29871651. doi:10.1186/s13063-018-2649-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。